Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study

OBJECTIVE: Ischemia-modified albumin (IMA) is a sensitive biomarker of myocardial ischemia. However, data on IMA levels in acute heart failure (HF) are still lacking. In this study, we aimed to evaluate serum IMA levels in acute decompensated HF and the effects of dobutamine and levosimendan treatme...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Anatol J Cardiol
Hoofdauteurs: Çavuşoğlu, Yüksel, Korkmaz, Şule, Demirtaş, Selda, Gencer, Erkan, Şaşmaz, Hatice, Mutlu, Fezan, Güneş, Hakan, Mert, Uğur Kadir, Özdemir, Sedat, Kalaycı, Süleyman, Yılmaz, Mehmet Birhan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Kare Publishing 2016
Onderwerpen:
Original Investigation
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5336859/
https://ncbi.nlm.nih.gov/pubmed/26301344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/akd.2015.6156
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items